Hypertension in FMR1 premutation males with and without fragile X‐associated tremor/ataxia syndrome (FXTAS)
Year: 2012
Type: article
Study design: Observational Study
Abstract: Fragile X-associated tremor ataxia syndrome (FXTAS) is a late onset neurodegenerative disease that affects carriers of the fragile X premutation. This study seeks to assess hypertension risk and susceptibility in male premutation carriers with FXTAS. Although many symptoms and diagnostic criteria have been identified, hypertension risk has not been examined in this population. Data from 92 premutation carriers without FXTAS, 100 premutation carriers with FXTAS, and 186 controls was collected via patient medical interview. Age-adjusted logistic regression analysis was used to examine the relative odds of hypertension. We observed a significantly elevated odds ratio (OR) of hypertension relative to controls for premutation carriers with FXTAS (OR = 3.22, 95% CI: 1.72-6.04; P = 0.0003) among participants over 40-year old. The age-adjusted estimated odds of hypertension in premutation carriers without FXTAS in the over 40-year-old age group was higher compared to controls (OR = 1.61, 95% CI: 0.82-3.16), but was not statistically significant (P = 0.164). Chronic hypertension contributes to cardiovascular complications, dementia, and increased risk of stroke. Our results indicate that the risk of hypertension is significantly elevated in male premutation carriers with FXTAS compared with carriers without FXTAS and controls. Thus, evaluation of hypertension in patients diagnosed with FXTAS should be a routine part of the treatment monitoring and intervention for this disease.
DOI: 10.1002/ajmg.a.35323
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
Funders: MIND Institute, University of California, Davis, National Institutes of Health, Centers for Disease Control and Prevention, University of California, Davis, National Institute on Aging, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Dental and Craniofacial Research, National Center for Research Resources, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: G1064348956, G1290979756, G1855666826, G1898880685, G2163302634, Development of targeted therapeutic agents for the treatment of FXTAS (2 of 6), G2973466140, Characterization and Treatment of CNS Abnormalities in Premutation Carriers (4 of, G3982541408, G4498805690, G4705397468, Research in Intellectual and Developmental Disabilities, Interdisciplinary Training Program in Neurotherapeutics (6 of 6), G6010579943, G802620026, G8694103996
OpenAlex ID: W2144646572
